Cytokines Interleukin-6 (IL-6) Levels in Mild Ischemic Heart Disease
Objective: To find the incidence of enhanced levels of IL-6 in angina pectoris.
Type of Study: Cross sectional study.
Place and Duration of study: This study was carried out in a duration of 6 months from February 2018 to July 2018 in Punjab Institute of Cardiology Lahore.
Materials and Methods: The patients presented with chest pain in PIC were studied and both genders were included in the study. The patients were between the ages of 30 to 70 years and had chest pain of shortness of breath. Only those patients were included in the study who were willing to take part in this study and had raised IL-6 levels. Informed consent was taken from all the patients and carefully designed proforma was used to collect the data of the patient. ECG was performed along with cardiac enzymes levels to rule of acute MI. blood sample was taken from the patients and sent to a reliable laboratory for analysis. Value of >5ng/ml was considered as high value.
Results: A total of 100 cases with angina were included in this study which had 59(59%) males and 41(41%) females. The patients were between the ages of 30 to 70 years with the mean age of 50 years. In 69% of the cases enhanced IL-6 levels were seen and gender difference was insignificant. Patients with diabetes and hypertension had increased IL-6 levels and 20 cases of DM had increased levels of IL-6 while 22 cases of HTN has increased levels.
Conclusion: Enhanced IL-6 levels are seen in patients with ischemia of cardiac tissues and the levels are higher in patients who have associated comorbidities like hypertension and diabetes mellitus.
Okrainec K, Banerjee DK, Eisenberg MJ. Coronary artery disease in the developing world. Am Heart J. 2004;148:7-15.
Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS et al. ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina— Summary Article. JACC. 2003;41:159-168.
Gibler WB ,Cannon CP, Blomkalns AL, Char DM , Drew BJ, Hollander JE et al. AHA Scientific Statement. Practical Implementation of the Guidelines for Unstable Angina /Non– ST-Segment Elevation Myocardial Infarction in the Emergency Department. Circulation. 2005;111:2699-2710.
Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA. Inflammatory and thrombotic mechanisms in coronary atherosclerosis (Re). Heart. 2003;89:993-97.
Tracy RP. Thrombin, Inflammation, and cardiovascular disease. Chest. 2003;124:49-59.
Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease. JAMA. 2003;290:932-940.
Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L. Circulating levels of proinflammatory cytokines and neutrophilplatelet aggregates in patients with coronary artery disease. Am J Cardiol. 2005;95:452-56.
Yamashita H, Shimada K, Seki E, Mokuno H, Daida H. Concentrations of interleukins, interferons, and CRP in stable and unstable angina pectoris. Am J Cardiol. 2003;91:133-36.
Lee KW, Lip GYH, Tayebjee M, Foster W and Blann AD.Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood. 2005;105:526-32.
Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767-72.
Luc G, Bard JM, Vague JI, Ferrieres J, Evans A, Amouyel P et al. CRP, Interleukin-6, and fibrinogen as predictors of coronary heart disease. The PRIME study. Arterioscler Thromb Vasc Biol. 2003;23:1255-61.
LaiS, Elliot K. FishmanG,Laih, Ph.D,PannuH. Serum IL-6 Levels are Associated with Significant Coronary Stenosis in Cardiovascularly Asymptomatic Inner-City Black Adults in the US. Inflamm Res,
Orak M, Ustundag M, Gulog C, Alyan O, Sayhan MB. The Role of Serum Ddimer Level in the Diagnosis of Patients Admitted to the Emergency Department Complaining of Chest Pain. J Int Med Research. 2010;38:1772-79.
Mahemuti A, Abudureheman K, Schiele F, Ecarnot F, Abudureyimu S, Tang B, et al. Association Between Inflammatory Markers, Hemostatic Markers, And Traditional Risk Factors On Coronary Artery Spasm In Patients With Normal Coronary Angiography. J Interv Cardiol. 2014;27(1):29-35.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.